Schedule 1 Therapeutics

Developing FDA and EMA approved therapies derived from cannabis to treat pain and central nervous system disorders.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Chicago, IL, USA
  • Currency USD
  • Founded July 2018
  • Employees 5
  • Incorporation Type C-corp
  • Website s1therapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free